Implantable Cardiac Pacemaker Market Business Growth Statistics and Key Players Insights Medtronic plc. BIOTRONIK, Boston Scientific Corporation, St. Jude Medical, Vitatron Holding, Shree Pacetronix, MEDICO S.p.A., Lepu Medical Technology, LivaNova

The global implantable cardiac pacemaker market was valued at US$ 4.7 billion in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026). The Global Implantable Cardiac Pacemaker Market, by Product Type (Single Chamber Pacemaker, Dual Chamber Pacemaker, and Biventricular Pacemaker), by Application (Heart Block, Arrhythmia, Atrial fibrillation, Long QT Syndrome, Bradycardia, Tachycardia, and Others), By End User (Hospitals, Emergency Care Centers, and Others) was valued US$ 4.7 billion in 2017 and is projected to exhibit a CAGR of 7.1% over the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.

Download PDF Copy as Sample Purpose @ https://www.coherentmarketinsights.com/insight/request-pdf/1663

Recent advances in implantable cardiac pacemakers have increased the safety and efficacy of cardiac pacemaker during implantation surgery procedures. Current advances in the cardiac pacemaker are majorly focused on improving cardiac resynchronization with multisite pacing, reduction of hardware allowing to reduce device failure, valve injury and minimizing the risk of device infection, and to develop battery-less cardiac pacemaker. Involvement of various research organizations in developing advanced implantable cardiac pacemaker is expected to boost the adoption of implantable cardiac pacemaker in near future.

Key players in implantable cardiac pacemaker market are focused on research and developmental activities for developing novel compact implantable cardiac pacemakers with better safety and at low cost, thereby increasing product acceptance by healthcare professionals and patients. Moreover, various key players are engaged in obtaining product approval from regulatory authority to increase their geographical reach.

Dual chamber pacemaker with two leads placed in right atrium a ventricle are projected to grow with higher pace during the forecasted period in the product type segment, owing to the higher efficiency and cost-effectiveness of dual chamber cardiac pacemaker in atrioventricular block or sick sinus syndrome.

Atrial Fibrillation hold major market share in application segment, due to increasing prevalence of Atrial Fibrillation among global population. Also, Atrial Fibrillation is as a major risk factor for developing majority of cardiovascular disease.

Hospitals holds largest market share in end user segment, owing to increasing volume of pacemaker implantation surgery procedures along with various technological advanced healthcare facility offered by hospitals.
Some of the major players operating in global implantable cardiac pacemaker market include Medtronic plc. BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical.

Request customization ( Add Region or Keyplayer as per your requirement) @
https://www.coherentmarketinsights.com/insight/request-customization/1663

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.